Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Kinaset Therapeutics has raised $103.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Kinaset Therapeutics's investors include RA Capital Management, Schroders Capital, Vivo Capital, EQT Life Sciences, 5AM Ventures.
Kinaset Therapeutics is headquartered in Boston, United States.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Kinaset Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kinaset Therapeutics — Funding & Investors." VCBacked, January 10, 2026, https://www.vcbacked.co/company/kinaset-therapeutics. Accessed September 2, 2026.
VCBacked. (2026). Kinaset Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/kinaset-therapeutics
{{cite web |title=Kinaset Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kinaset-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated